ArticleWorld journal of psychiatry2025
Illness uncertainty, anxiety, and depression in primary glaucoma and associated influencing factors.
Article in World journal of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Research progress on glaucoma complicated with anxiety and depression.International journal of ophthalmology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlaucoma, a condition frequently linked to severe depression, anxiety, and sleep disturbances, affects treatment adherence while potentially compromising effectiveness.
aimTo explore illness uncertainty (IU), anxiety, and depressive symptoms in primary glaucoma and to discuss underlying triggers.
methodsWe recruited 120 primary glaucoma cases between January 2022 and November 2023. The Mishel Uncertainty in Illness Scale (MUIS) and the Hospital Anxiety and Depression Scale (HADS) [include HADS-anxiety subscale (HADS-A) and HADS-depression subscale (HADS-D)] subscales, were used to assess IU and emotional distress (anxiety/depression), respectively. The MUIS-HADS subscale interrelationships were determined by Pearson correlation. IU-associated determinants were identified using univariate and binary logistic regression analyses.
resultsThe cohort showed a mean MUIS score of 79.73 ± 8.97, corresponding to a moderately high IU level. The HADS-A and HADS-D scores averaged 6.57 ± 3.89 and 7.08 ± 5.05 points, respectively, with 15.00% of participants showing anxiety symptoms and 24.17% exhibiting depressive signs. Significant positive connections were observed between MUIS and both HADS-A (
conclusionPatients with primary glaucoma experience moderate IU levels, generally low anxiety, and mild depression. Specifically, the anxiety and depression risks were 15.00% and 24.17%, respectively. A significant positive correlation existed between IU and anxiety/depression in these patients. Additionally, insomnia or lower monthly household income elevated anxiety/depression risks, enabling reliable anxiety/depression risk categorization among patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.